These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11223439)

  • 1. Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in onset of acute myocardial infarction.
    Fujino T; Katou J; Fujita M; Ohta T; Harada T; Hasebe N; Kikuchi K
    Atherosclerosis; 2001 Mar; 155(1):171-8. PubMed ID: 11223439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
    Haider AW; Andreotti F; Thompson GR; Kluft C; Maseri A; Davies GJ
    Circulation; 1996 Nov; 94(9):2072-6. PubMed ID: 8901653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction.
    Takazoe K; Ogawa H; Yasue H; Sakamoto T; Oshima S; Arai H; Moriyama Y; Shimomura H; Hirai N; Kaikita K; Soejima H; Misumi K; Hosoda K
    Thromb Res; 1999 Jul; 95(1):37-47. PubMed ID: 10403685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
    Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
    Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction.
    Honda Y; Oshima S; Ogawa H; Sakamoto T; Miyao Y; Sakata S; Hirashima O; Moriyama Y; Yasue H
    Jpn Circ J; 1994 Dec; 58(12):869-76. PubMed ID: 7699733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
    Ganti AK; Potti A; Yegnanarayan R
    Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
    Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
    Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
    Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest.
    Figueras J; Monasterio Y; Lidón RM; Nieto E; Soler-Soler J
    J Am Coll Cardiol; 2000 Dec; 36(7):2036-43. PubMed ID: 11127437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
    Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
    Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lipoprotein-a on thrombolytic therapy and spontaneous reperfusion in acute myocardial infarction. A comparative study.
    Dagdelen S; Eren N; Akdemir I; Karabulut H; Ergelen M; Caglar N
    Int Angiol; 2002 Dec; 21(4):384-9. PubMed ID: 12518121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoprotein(a) changes in acute myocardial infarction.
    Motta M; Giugno I; Bosco S; Pistone G; Ruello P; Maugeri D; Malaguarnera M
    Panminerva Med; 2001 Jun; 43(2):77-80. PubMed ID: 11449175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
    Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
    Huisse MG; Ajzenberg N; Feldman L; Guillin MC; Steg PG
    Thromb Haemost; 2009 Apr; 101(4):734-40. PubMed ID: 19350119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
    Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
    Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.
    Hikita H; Shigeta T; Kojima K; Oosaka Y; Hishikari K; Kawaguchi N; Nakashima E; Sugiyama T; Akiyama D; Kamiishi T; Kimura S; Takahashi Y; Kuwahara T; Sato A; Takahashi A; Isobe M
    Coron Artery Dis; 2013 Aug; 24(5):381-5. PubMed ID: 23652366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.